PubMed HealthSearch

Biomedical subjects

C J Gilmore

Publications and source records attributed to C J Gilmore.

5 recordsLinked to original sources

A multisolution method of phase determination by combined maximization of entropy and likelihood. V. The use of likelihood as a discriminator of phase sets produced by the SAYTAN program for a small protein.

The use of a likelihood criterion associated with maximum-entropy (ME) extrapolation for selecting phase sets as part of a new multisolution phasing strategy, already applied to solving small crystal structures from single-crystal data [Gilmore, Bricogne & Bannister (1990). Acta Cryst. A46, 297-308] and X-ray powder diffraction data [Gilmore, Henderson & Bricogne (1991). Acta Cryst. A47, 830-841], has been tested on the small protein avian pancreatic polypeptide (APP) with 301 non-H atoms in the asymmetric unit in space group C2. A collection of 50 phase sets for APP were provided by Woolfson & Yao. They had been generated from random starting phases by the SAYTAN procedure [Woolfson & Yao (1990). Acta Cryst. A46, 409-413] using data to a resolution of 0.98 A. Six of these had an unweighted mean absolute phase error, mean value of magnitude of delta phi, of less than 50 degrees, the remainder having phase errors of 60 degrees or more. However, none of the conventional figures of merit were able to identify these preferred sets. Each phase set was subjected to our standard procedure of entropy maximization and of evaluation of the log-likelihood gain resulting from the associated ME extrapolation. With only a small subset of data (to 2 A resolution), the likelihood criterion identified unambiguously the phase sets with mean value of magnitude of delta phi less than 50 degrees. In contrast, conventional figures of merit showed no such ability.(ABSTRACT TRUNCATED AT 250 WORDS)

Pancreatic Polypeptide

Penicillin G or ampicillin for oral treatment of canine urinary tract infections.

Penicillin G or ampicillin was administered orally to 144 dogs with urinary tract infections. The daily dosage of penicillin G ranged from 110,000 to 165,000 U/kg (50,000-75,000 U/lb), and the dosage of ampicillin varied from 77 to 110 mg/kg (35-50 mg/lb). The daily dose of each antibiotic was divided into 3 or 4 doses and given at approximately 8- or 6-hour intervals for 10 to 14 days. Response to treatment, based on results of urine culture, varied from no response for infections caused by Pseudomonas spp to 100% response for those caused by Staphylococcus aureus and Streptococcus spp. About 50% of infections caused by Escherichia coli were eliminated, as were about 80% of those due to Proteus mirabilis. Mean concentrations of penicillin G and ampicillin in urines collected at 6-hour intervals after oral administration to clinically normal adult dogs were approximately 350 microgram/ml for both drugs when each was given individually in daily dosages (divided QID) of 55 mg/kg (25 mg/lb). The minimum inhibitory concentration of penicillin G for a number of the bacteria isolated from the urine of the infected dogs was compared with the results of the clinical trials and to the minimum inhibitory concentration of a larger number of urinary bacterial isolates.

Administration, Oral